---
title: "Top 10 港股跌幅（11月19日）"
description: "奇富科技-S(03660) 跌 11.47%，成交额 1859.0 万港元，年内累计跌 45.7%。 百奧賽圖-B(02315) 跌 8.84%，成交额 3435.0 万港元，年内累计涨 256.5%。 中國港能 (00931) 跌 7.53%，成交额 2304.3 万港元，年内累计涨 16.2%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/266502728.md"
published_at: "2025-11-19T08:30:42.000Z"
---

# Top 10 港股跌幅（11月19日）

> 奇富科技-S(03660) 跌 11.47%，成交额 1859.0 万港元，年内累计跌 45.7%。 百奧賽圖-B(02315) 跌 8.84%，成交额 3435.0 万港元，年内累计涨 256.5%。 中國港能 (00931) 跌 7.53%，成交额 2304.3 万港元，年内累计涨 16.2%。

恆生指數跌 0.38%，年内累計涨 28.8%；恆生科技指數跌 0.69%，年内累計涨 25.5%。

奇富科技-S(03660) 跌 11.47%，成交额 1859.0 万港元，年内累计跌 45.7%。

百奧賽圖-B(02315) 跌 8.84%，成交额 3435.0 万港元，年内累计涨 256.5%。

中國港能 (00931) 跌 7.53%，成交额 2304.3 万港元，年内累计涨 16.2%。

### Related Stocks

- [03660.HK - 奇富科技-S](https://longbridge.com/zh-HK/quote/03660.HK.md)
- [02315.HK - 百奧賽圖-B](https://longbridge.com/zh-HK/quote/02315.HK.md)
- [00931.HK - 中國港能](https://longbridge.com/zh-HK/quote/00931.HK.md)
- [02579.HK - 中偉新材](https://longbridge.com/zh-HK/quote/02579.HK.md)
- [02591.HK - 銀諾醫藥-B](https://longbridge.com/zh-HK/quote/02591.HK.md)
- [00326.HK - 中國星集團](https://longbridge.com/zh-HK/quote/00326.HK.md)
- [01931.HK - 華檢醫療](https://longbridge.com/zh-HK/quote/01931.HK.md)
- [02096.HK - 先聲藥業](https://longbridge.com/zh-HK/quote/02096.HK.md)
- [02245.HK - 力勤資源](https://longbridge.com/zh-HK/quote/02245.HK.md)
- [00638.HK - 廣和通](https://longbridge.com/zh-HK/quote/00638.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Biocytogen Sets Out Board Structure and Committee Roles | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. has announced its board structure, led by Chairman and CEO Dr. Shen Yuelei | [Link](https://longbridge.com/zh-HK/news/275756980.md) |
| Biocytogen Pharmaceuticals Beijing Co. Ltd. Announces Date for First Extraordinary General Meeting in 2026 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. will hold its first extraordinary general meeting on February 12, 2026, a | [Link](https://longbridge.com/zh-HK/news/273877900.md) |
| CNGR Shareholders Approve External Financial Assistance Plan at 2026 EGM | CNGR Advanced Material Co., Ltd. held its extraordinary general meeting on February 12, 2026, where shareholders represe | [Link](https://longbridge.com/zh-HK/news/275804927.md) |
| Fibocom Wireless Unveils 2026 Employee Stock Ownership Plan | Fibocom Wireless Inc. has proposed a 2026 Employee Stock Ownership Plan (ESOP), pending approval at an Extraordinary Gen | [Link](https://longbridge.com/zh-HK/news/275374950.md) |
| Biocytogen Forecasts Profit Surge on Overseas Expansion and Industry Recovery in 2025 | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. forecasts a revenue increase of 40% for 2025, projecting RMB1.37 billion t | [Link](https://longbridge.com/zh-HK/news/274121607.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。